| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 594.54 KB | Adobe PDF |
Abstract(s)
Introdução: O envelhecimento é uma fase do ciclo vital com marcadas diferenças interindividuais, no estado de saúde física e cognitiva, sendo uma etapa em que existe uma elevada prevalência de patologias. Entre as doenças crónicas não transmissíveis, a diabetes mellitus tipo 2 (DM2) evidencia-se como sendo uma importante causa de morbilidade e mortalidade, particularmente entre os idosos. A DM2 tem sido indicada como um importante fator de risco para comprometimento cognitivo na velhice.
Objetivos: Este estudo enquadrou-se no projeto “ICON – Desafios Interdisciplinares em Neurodegenerac¸ão” (em curso no Centro de Investigação em Ciências da Saúde da UBI) e teve como objetivos: caraterizar o nível clínico e sociodemográfico de um grupo de pessoas idosas institucionalizadas em lares da 3ª idade com diagnóstico de DM2; avaliar o estado cognitivo dos participantes; averiguar se existem diferenças a nível cognitivo entre participantes com diferentes características clínicas; analisar se existem diferenças ao nível da hemoglobina glicada entre idosos com e sem défice cognitivo (DC).
Métodos: Participaram no estudo 61 indivíduos com diagnóstico de DM2 (14 homens, 47 mulheres, idade média 82,0 ± 7,0 anos, intervalo 65-97 anos), residentes em lares da Beira Interior. Foram avaliados através do “Mini-Mental State Examination” e da “Global Deterioration Scale”, tendo sido recolhidos os dados relativos ao índice de massa corporal, hemoglobina glicada, avaliações médicas, diagnósticos e medicação.
Resultados: Relativamente à medicação, 95,1% tomavam fármacos hipoglicemiantes (8,2% insulina e 86,9% antidiabéticos orais) e 4,9% faziam apenas dieta. Apenas 20 doentes (32,8%) apresentaram, pelo menos, um registo de hemoglobina glicada nos 6 meses anteriores ou posteriores à data da avaliação cognitiva, através do Mini Mental State Examination. Os resultados não revelaram diferenças estatisticamente significativas do valor médio da hemoglobina glicada entre o grupo com e sem DC (6,84 ± 1,15 vs. 6,55 ± 0,50, teste de Mann-Whitney, U=16,0, p=0,801).
Conclusão: Esta investigação alerta para a complexidade, os desafios e as barreiras relacionadas com a população idosa institucionalizada com DM2, nomeadamente a falta de registos atuais da hemoglobina glicada e a possível ausência de registo de complicações microvasculares.
Introduction: Aging is a phase of the life cycle with marked interindividual differences in the state of physical and cognitive health. This stage is characterized by a high prevalence of pathologies. Among the non-communicable chronic diseases, type 2 diabetes mellitus (T2DM) is an important cause of morbidity and mortality, particularly among the elderly. T2DM has been indicated as an important risk factor for cognitive impairment in older people. Objectives: This study was part of the ICON - Interdisciplinary Challenges in Neurodegeneration project (underway at the UBI Health Sciences Research Center) and had the following objectives: to characterize the clinical and socio-demographic level of a group of elderly people institutionalized in nursing homes with T2DM diagnosis; assess the cognitive status of the participants; to investigate whether there are differences at a cognitive level among participants with different clinical characteristics; to analyze if there are differences in glycated hemoglobin between elderly with and without cognitive deficit. Methods: A total of 61 individuals diagnosed with T2DM (14 males, 47 females, mean age of 82.0 ± 7.0 years, range 65-97 years) were enrolled in the study. They were evaluated through the Mini-Mental State Examination and the Global Deterioration Scale, and the following data were collected: body mass index, glycated hemoglobin, medical evaluations, diagnoses and medication. Results: 95.1% took hypoglycemic drugs (8.2% insulin and 86.9% oral antidiabetics) and 4.9% were on a diet only. Only 20 patients (32.8%) had at least one glycated hemoglobin record in the 6 months prior or after the cognitive assessment data with Mini Mental State Examination. The results did not reveal statistically significant differences in the mean value of glycated hemoglobin between the group with and without cognitive deficit (6.84 ± 1.15 vs. 6.55 ± 0.50, Mann-Whitney test, U=16.0, p=0.801). Conclusion: This research alerts to the complexity, challenges and barriers related to the elderly population institutionalized with T2DM, namely the lack of current records of glycated hemoglobin and the possible lack of records of microvascular complications.
Introduction: Aging is a phase of the life cycle with marked interindividual differences in the state of physical and cognitive health. This stage is characterized by a high prevalence of pathologies. Among the non-communicable chronic diseases, type 2 diabetes mellitus (T2DM) is an important cause of morbidity and mortality, particularly among the elderly. T2DM has been indicated as an important risk factor for cognitive impairment in older people. Objectives: This study was part of the ICON - Interdisciplinary Challenges in Neurodegeneration project (underway at the UBI Health Sciences Research Center) and had the following objectives: to characterize the clinical and socio-demographic level of a group of elderly people institutionalized in nursing homes with T2DM diagnosis; assess the cognitive status of the participants; to investigate whether there are differences at a cognitive level among participants with different clinical characteristics; to analyze if there are differences in glycated hemoglobin between elderly with and without cognitive deficit. Methods: A total of 61 individuals diagnosed with T2DM (14 males, 47 females, mean age of 82.0 ± 7.0 years, range 65-97 years) were enrolled in the study. They were evaluated through the Mini-Mental State Examination and the Global Deterioration Scale, and the following data were collected: body mass index, glycated hemoglobin, medical evaluations, diagnoses and medication. Results: 95.1% took hypoglycemic drugs (8.2% insulin and 86.9% oral antidiabetics) and 4.9% were on a diet only. Only 20 patients (32.8%) had at least one glycated hemoglobin record in the 6 months prior or after the cognitive assessment data with Mini Mental State Examination. The results did not reveal statistically significant differences in the mean value of glycated hemoglobin between the group with and without cognitive deficit (6.84 ± 1.15 vs. 6.55 ± 0.50, Mann-Whitney test, U=16.0, p=0.801). Conclusion: This research alerts to the complexity, challenges and barriers related to the elderly population institutionalized with T2DM, namely the lack of current records of glycated hemoglobin and the possible lack of records of microvascular complications.
Description
Keywords
Diabetes Mellitus Tipo 2 Endocrinologia Envelhecimento Estado Cognitivo Hemoglobina Glicada Icon Institucionalização